Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa versus placebo in Friedreich's ataxia
2007-007653-31Phase 2Active
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2008
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Friedreich ataxia (FA) comparing Darbepoetin alfa with Placebo (2 arms). Primary endpoints: Neurological evaluation by ICARS, Neurological evaluation by FARS and 1 more. Started Jun 2008; status: active.
02
Drugs
darbepoetin alfa
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2007-007653-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007653-31.